Edgewise Therapeutics, Inc. (EWTX) Reports In-Line Q1 EPS

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q1 EPS of ($0.43), in-line with the analyst estimate of ($0.43).

For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.

You May Also Be Interested In

• Winnebago Industries (WGO) Misses Q3 EPS by 11c ; Offers Guidance
• SanDisk stock target lifted by Citi on continued demand strength
• Uber (UBER) Reiterated at Market Outperform by Citizens as Rider-Only Miles Grow